What is Forever Labs?
Founded in 2015, Forever Labs operates at the intersection of biotechnology and preventative healthcare. The company specializes in the collection and cryopreservation of adult stem cells, providing a biological insurance policy for clients aiming to mitigate the effects of aging. By offering these services directly to individuals and as a value-added benefit for corporate employers, Forever Labs has carved out a unique niche in the health-tech landscape. Their business model is built upon the premise that early intervention and the preservation of high-quality cellular material are critical components of future-proofed health strategies, effectively bridging the gap between current medical capabilities and the future of regenerative therapies.
How much funding has Forever Labs raised?
Forever Labs has raised a total of $2.1M across 2 funding rounds:
Other Financing Round
$2M
Debt
$146K
Other Financing Round (2018): $2M, investors not publicly disclosed
Debt (2021): $146K led by PPP
Key Investors in Forever Labs
PPP
Public-Private Partnership
Undisclosed Investor
An institutional backer participating in the initial financing rounds to support the foundational development of regenerative medicine infrastructure.
Undisclosed Investor
A strategic partner providing capital to facilitate the expansion of stem cell storage services and long-term health research.
What's next for Forever Labs?
Looking ahead, the recent influx of capital will likely be directed toward enhancing the company's laboratory capabilities and expanding its market reach. As the demand for longevity-focused interventions grows, Forever Labs is expected to leverage its current financial standing to deepen its research partnerships and streamline its logistics network. The focus will remain on scaling the accessibility of stem cell storage while maintaining the rigorous standards required for clinical-grade biological preservation. By integrating these services into broader corporate wellness programs, the firm is poised to capture a larger share of the enterprise health benefits market, further cementing its role as a leader in the longevity medicine ecosystem.
See full Forever Labs company page
